1. Home
  2. EMBC vs BGB Comparison

EMBC vs BGB Comparison

Compare EMBC & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$9.63

Market Cap

602.3M

Sector

Health Care

ML Signal

N/A

Logo Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

BGB

Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

N/A

Current Price

$11.23

Market Cap

527.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
EMBC
BGB
Founded
1924
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
602.3M
527.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EMBC
BGB
Price
$9.63
$11.23
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.50
N/A
AVG Volume (30 Days)
905.0K
142.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
6.24%
9.75%
EPS Growth
20.90
N/A
EPS
0.74
N/A
Revenue
N/A
N/A
Revenue This Year
$1.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.20
$10.47
52 Week High
$15.55
$12.65

Technical Indicators

Market Signals
Indicator
EMBC
BGB
Relative Strength Index (RSI) 32.22 25.95
Support Level $9.45 N/A
Resistance Level $10.88 $12.02
Average True Range (ATR) 0.33 0.08
MACD -0.04 -0.03
Stochastic Oscillator 4.08 21.09

Price Performance

Historical Comparison
EMBC
BGB

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

Blackstone Strategic Credit Fund is a closed-end term fund. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.

Share on Social Networks: